Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Johnson
Dale N Gerding

Showing results (91-100 of 283) with videos related to

Pageof 29
Sort By:
Infection and Immunity|January 31, 2014
Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient micePehga F Johnston, Dale N Gerding, Katherine L Knight
Infectious Diseases in Clinical Practice (Baltimore, Md.)|January 20, 2018
Diagnosis and Treatment of <i>Clostridium difficile</i> Infection (CDI)Dale N Gerding, Thomas M File, L Clifford McDonald
Infection Control and Hospital Epidemiology|February 8, 2013
Effectiveness of hand hygiene for removal of Clostridium difficile spores from handsSarah L Edmonds, Carrie Zapka, Douglas Kasper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2008
Treatment of Clostridium difficile infectionDale N Gerding, Carlene A Muto, Robert C Owens
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2014
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trialsStuart Johnson, Thomas J Louie, Dale N Gerding, et al.
Journal of Clinical Medicine|January 5, 2021
The Relative Role of Toxins A and B in the Virulence of <i>Clotridioides difficile</i>Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, et al.
Anaerobe|June 11, 2018
Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015Adam Cheknis, Stuart Johnson, Laurent Chesnel, et al.
Anaerobe|September 10, 2009
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007Adam K Cheknis, Susan P Sambol, David M Davidson, et al.
Emerging Infectious Diseases|July 5, 2008
Toxinotype V Clostridium difficile in humans and food animalsMichael A Jhung, Angela D Thompson, George E Killgore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2020
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor OutcomesStuart Johnson, Diane M Citron, Dale N Gerding, et al.
Pageof 29

Showing results (91-100 of 283) with videos related to

Sort By:
Pageof 29
Infection and Immunity|January 31, 2014
Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient micePehga F Johnston, Dale N Gerding, Katherine L Knight
Infectious Diseases in Clinical Practice (Baltimore, Md.)|January 20, 2018
Diagnosis and Treatment of <i>Clostridium difficile</i> Infection (CDI)Dale N Gerding, Thomas M File, L Clifford McDonald
Infection Control and Hospital Epidemiology|February 8, 2013
Effectiveness of hand hygiene for removal of Clostridium difficile spores from handsSarah L Edmonds, Carrie Zapka, Douglas Kasper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2008
Treatment of Clostridium difficile infectionDale N Gerding, Carlene A Muto, Robert C Owens
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2014
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trialsStuart Johnson, Thomas J Louie, Dale N Gerding, et al.
Journal of Clinical Medicine|January 5, 2021
The Relative Role of Toxins A and B in the Virulence of <i>Clotridioides difficile</i>Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, et al.
Anaerobe|June 11, 2018
Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015Adam Cheknis, Stuart Johnson, Laurent Chesnel, et al.
Anaerobe|September 10, 2009
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007Adam K Cheknis, Susan P Sambol, David M Davidson, et al.
Emerging Infectious Diseases|July 5, 2008
Toxinotype V Clostridium difficile in humans and food animalsMichael A Jhung, Angela D Thompson, George E Killgore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2020
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor OutcomesStuart Johnson, Diane M Citron, Dale N Gerding, et al.
Pageof 29